June 25, 2018:
Biotech 3D printing startup BioLife4D has successfully produced human tissue in the form of a cardiac patch, the company announced on Monday, bringing it one step closer to printing organs viable for transplant.
“What’s interesting about this is that it’s being 3D bioprinted,” Joseph Woo, MD, the chair of the Department of Cardiothoracic Surgery at Stanford University, told Yahoo Finance. “Instead of constructing it by hand in a dish, you can 3D print it on the dish.”
BioLife4D says the bioprinted cardiac patches could bring significant cost and time savings by making the creation process scalable. The company, which has raised more than $1 million selling public securities, aims to eventually produce organs on demand.
Read more HERE